TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1320900
log Bayes Factor = 0.0586687
Chromosome 3   position 131,713,566  (GRCh37) Explore rs1320900 on Ensembl!
Variant rs1320900 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T42.4 Benzodiazepines
0.000 0.906 0.094
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.907 0.093
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.909 0.091
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.917 0.083
I12.0 Hypertensive renal disease with renal failure
0.000 0.920 0.080
B95.7 Other staphylococcus as the cause of diseases classified to other chapters
0.078 0.922 0.000
T42.1 Iminostilbenes
0.000 0.927 0.073
T42.0 Hydantoin derivatives
0.000 0.930 0.069
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.932 0.068
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.933 0.067
T42.3 Barbiturates
0.000 0.933 0.067
T42.2 Succinimides and oxazolidinediones
0.000 0.933 0.067
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.957 0.043
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.960 0.040
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.961 0.039
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.962 0.038
T46.1 Calcium-channel blockers
0.000 0.965 0.035
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.966 0.034
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.966 0.034
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.968 0.032
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.968 0.032
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.969 0.031
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.969 0.031
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.969 0.031
T45.0 Antiallergic and antiemetic drugs
0.000 0.969 0.031
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.969 0.030
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.970 0.030
T50.4 Drugs affecting uric acid metabolism
0.000 0.970 0.030
T36 Poisoning by systemic antibiotics
0.000 0.971 0.029
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.971 0.028
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.971 0.028
T46.7 Peripheral vasodilators
0.000 0.971 0.028
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.971 0.028
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.971 0.028
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.972 0.028
T50.7 Analeptics and opioid receptor antagonists
0.000 0.972 0.028
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.972 0.028
T50.5 Appetite depressants
0.000 0.972 0.028
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.972 0.028
T50.1 Loop [high-ceiling] diuretics
0.000 0.972 0.028
T50.0 Mineralocorticoids and their antagonists
0.000 0.972 0.028
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.972 0.028
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.972 0.028
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.973 0.027
I12 Hypertensive renal disease
0.000 0.973 0.027
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.974 0.026
T43.6 Psychostimulants with abuse potential
0.000 0.974 0.026
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.974 0.025
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.975 0.025
T43.9 Psychotropic drug, unspecified
0.000 0.975 0.025
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.975 0.025
T50.8 Diagnostic agents
0.000 0.975 0.025
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.975 0.025
T45.8 Other primarily systemic and haematological agents
0.000 0.975 0.025
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.975 0.025
T45.6 Fibrinolysis-affecting drugs
0.000 0.975 0.025
T45.4 Iron and its compounds
0.000 0.975 0.025
T45.3 Enzymes, not elsewhere classified
0.000 0.975 0.025
T43.2 Other and unspecified antidepressants
0.000 0.975 0.025
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.975 0.025
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.975 0.024
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.976 0.024
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.977 0.023
O42.9 Premature rupture of membranes, unspecified
0.000 0.977 0.023
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.977 0.023
T48.5 Anti-common-cold drugs
0.000 0.977 0.023
T48.4 Expectorants
0.000 0.977 0.023
T48.3 Antitussives
0.000 0.977 0.023
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.977 0.023
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.977 0.023
T48.0 Oxytocic drugs
0.000 0.977 0.023
T45.2 Vitamins, not elsewhere classified
0.000 0.977 0.022
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts
0.023 0.977 0.000
T41.5 Therapeutic gases
0.000 0.978 0.022
T41.4 Anaesthetic, unspecified
0.000 0.978 0.022
T41.3 Local anaesthetics
0.000 0.978 0.022
T41.2 Other and unspecified general anaesthetics
0.000 0.978 0.022
T41.1 Intravenous anaesthetics
0.000 0.978 0.022
T41.0 Inhaled anaesthetics
0.000 0.978 0.022
T49.9 Topical agent, unspecified
0.000 0.978 0.022
T49.8 Other topical agents
0.000 0.978 0.022
T49.7 Dental drugs, topically applied
0.000 0.978 0.022
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.978 0.022
T49.5 Ophthalmological drugs and preparations
0.000 0.978 0.022
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.978 0.022
T49.3 Emollients, demulcents and protectants
0.000 0.978 0.022
T49.2 Local astringents and local detergents
0.000 0.978 0.022
T49.1 Antipruritics
0.000 0.978 0.022
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.978 0.022
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.978 0.022
T45.5 Anticoagulants
0.000 0.978 0.022
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.979 0.021
T36.9 Systemic antibiotic, unspecified
0.000 0.979 0.021
T36.8 Other systemic antibiotics
0.000 0.979 0.021
T36.7 Antifungal antibiotics, systemically used
0.000 0.979 0.021
T36.6 Rifamycins
0.000 0.979 0.021
T36.5 Aminoglycosides
0.000 0.979 0.021
T36.4 Tetracyclines
0.000 0.979 0.021
T36.2 Chloramphenicol group
0.000 0.979 0.021
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.979 0.021
T36.3 Macrolides
0.000 0.980 0.020
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.980 0.020
T37.5 Antiviral drugs
0.000 0.980 0.020
T37.4 Anthelminthics
0.000 0.980 0.020
T37.3 Other antiprotozoal drugs
0.000 0.980 0.020
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.980 0.020
T37.1 Antimycobacterial drugs
0.000 0.980 0.020
T37.0 Sulphonamides
0.000 0.980 0.020
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.980 0.020
T36.0 Penicillins
0.000 0.980 0.019
T47.0 Histamine H(2)-receptor antagonists
0.000 0.981 0.019
T38.1 Thyroid hormones and substitutes
0.000 0.981 0.019
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.981 0.018
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.981 0.018
T47.7 Emetics
0.000 0.981 0.018
T47.6 Antidiarrhoeal drugs
0.000 0.981 0.018
T47.5 Digestants
0.000 0.981 0.018
T47.3 Saline and osmotic laxatives
0.000 0.981 0.018
T47.2 Stimulant laxatives
0.000 0.981 0.018
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.982 0.018
T38.9 Other and unspecified hormone antagonists
0.000 0.982 0.018
T38.7 Androgens and anabolic congeners
0.000 0.982 0.018
T38.5 Other oestrogens and progestogens
0.000 0.982 0.018
T38.4 Oral contraceptives
0.000 0.982 0.018
T38.2 Antithyroid drugs
0.000 0.982 0.018
T38.0 Glucocorticoids and synthetic analogues
0.000 0.982 0.018
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.982 0.018
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.983 0.017
T39.4 Antirheumatics, not elsewhere classified
0.000 0.983 0.017
T39.2 Pyrazolone derivatives
0.000 0.983 0.017
T47.4 Other laxatives
0.000 0.983 0.016
N81.2 Incomplete uterovaginal prolapse
0.000 0.984 0.016
Z13.1 Special screening examination for diabetes mellitus
0.016 0.984 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.984 0.016
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.984 0.016
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.984 0.016
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.984 0.016
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.984 0.016
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.984 0.016
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.984 0.016
T44.0 Anticholinesterase agents
0.000 0.984 0.016
N08.3 Glomerular disorders in diabetes mellitus
0.000 0.984 0.016
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.985 0.015
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.985 0.015
O42 Premature rupture of membranes
0.000 0.985 0.015
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.985 0.014
O42.0 Premature rupture of membranes, onset of labour within 24 hours
0.000 0.987 0.013
T39.0 Salicylates
0.000 0.987 0.013
I12.9 Hypertensive renal disease without renal failure
0.000 0.988 0.012
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.988 0.012
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.989 0.011
K82.1 Hydrops of gallbladder
0.011 0.989 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.989 0.011
T40.5 Cocaine
0.000 0.989 0.011
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.989 0.011
T40.8 Lysergide [LSD]
0.000 0.989 0.011
T40.7 Cannabis (derivatives)
0.000 0.989 0.011
T40.3 Methadone
0.000 0.989 0.011
T40.0 Opium
0.000 0.989 0.011
T40.1 Heroin
0.000 0.989 0.011
O42.2 Premature rupture of membranes, labour delayed by therapy
0.000 0.989 0.011
H04.5 Stenosis and insufficiency of lachrymal passages
0.000 0.990 0.010
O42.1 Premature rupture of membranes, onset of labour after 24 hours
0.000 0.990 0.010
S61.9 Open wound of wrist and hand, part unspecified
0.000 0.990 0.010
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.990 0.009
K65.0 Acute peritonitis
0.000 0.991 0.009
T40.4 Other synthetic narcotics
0.000 0.991 0.008
R09.1 Pleurisy
0.000 0.991 0.009
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.008 0.992 0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)
0.008 0.992 0.000
T40.6 Other and unspecified narcotics
0.000 0.992 0.008
N08 Glomerular disorders in diseases classified elsewhere
0.000 0.992 0.008
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.008 0.992 0.000
R09 Other symptoms and signs involving the circulatory and respiratory systems
0.000 0.992 0.007
R09.2 Respiratory arrest
0.000 0.993 0.007
I10-I15 Hypertensive diseases
0.000 0.993 0.007
T40.2 Other opioids
0.000 0.993 0.007
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.007 0.993 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.007 0.993 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.007 0.993 0.000
C88 Malignant immunoproliferative diseases
0.007 0.993 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.007 0.993 0.000
R09.3 Abnormal sputum
0.000 0.993 0.007
R09.0 Asphyxia
0.000 0.993 0.007
I15 Secondary hypertension
0.000 0.993 0.007
C85.1 B-cell lymphoma, unspecified
0.007 0.993 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.006 0.994 0.000
C95 Leukaemia of unspecified cell type
0.006 0.994 0.000
C91 Lymphoid leukaemia
0.006 0.994 0.000
C91.4 Hairy-cell leukaemia
0.006 0.994 0.000
I15.1 Hypertension secondary to other renal disorders
0.000 0.994 0.006
K82.8 Other specified diseases of gallbladder
0.006 0.994 0.000
C93 Monocytic leukaemia
0.006 0.994 0.000
N18.9 Chronic renal failure, unspecified
0.000 0.994 0.006
K82 Other diseases of gallbladder
0.006 0.994 0.000
C90.0 Multiple myeloma
0.006 0.994 0.000
C85.0 Lymphosarcoma
0.006 0.994 0.000
N03.9 Unspecified
0.000 0.994 0.006
C90.2 Plasmacytoma, extramedullary
0.006 0.994 0.000
C90.1 Plasma cell leukaemia
0.006 0.994 0.000
N08.8 Glomerular disorders in other diseases classified elsewhere
0.000 0.994 0.006
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.000 0.994 0.006
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.000 0.994 0.006
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.000 0.994 0.006
C95.9 Leukaemia, unspecified
0.006 0.994 0.000
H61.2 Impacted cerumen
0.006 0.994 0.000
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts
0.006 0.994 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.006 0.994 0.000
C93.1 Chronic monocytic leukaemia
0.006 0.994 0.000
M65.4 Radial styloid tenosynovitis [de Quervain]
0.006 0.994 0.000
C91.1 Chronic lymphocytic leukaemia
0.006 0.994 0.000
K82.0 Obstruction of gallbladder
0.005 0.994 0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters
0.006 0.994 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.005 0.995 0.000
I15.9 Seconday hypertension, unspecified
0.000 0.995 0.005
I13 Hypertensive heart and renal disease
0.000 0.995 0.005
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis
0.005 0.995 0.000
N08.5 Glomerular disorders in systemic connective tissue disorders
0.000 0.995 0.005
T82.0 Mechanical complication of heart valve prosthesis
0.005 0.995 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.005 0.995 0.000
C94 Other leukaemias of specified cell type
0.005 0.995 0.000
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters
0.005 0.995 0.000
O04.9 Complete or unspecified, without complication
0.005 0.995 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.005 0.995 0.000
C88.7 Other malignant immunoproliferative diseases
0.005 0.995 0.000
C88.3 Immunoproliferative small intestinal disease
0.005 0.995 0.000
C88.2 Gamma heavy chain disease
0.005 0.995 0.000
C88.1 Alpha heavy chain disease
0.005 0.995 0.000
K82.2 Perforation of gallbladder
0.005 0.995 0.000
N08.1 Glomerular disorders in neoplastic diseases
0.000 0.995 0.005
I11 Hypertensive heart disease
0.000 0.995 0.005
I15.8 Other secondary hypertension
0.000 0.995 0.005
I15.2 Hypertension secondary to endocrine disorders
0.000 0.995 0.005
C83 Diffuse non-Hodgkin's lymphoma
0.005 0.995 0.000
C86 Other specified types of T/NK-cell lymphoma
0.005 0.995 0.000
N03 Chronic nephritic syndrome
0.000 0.995 0.005
C95.7 Other leukaemia of unspecified cell type
0.005 0.995 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.005 0.995 0.000
C91.9 Lymphoid leukaemia, unspecified
0.005 0.995 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.005 0.995 0.000
C91.7 Other lymphoid leukaemia
0.005 0.995 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.005 0.995 0.000
C91.3 Prolymphocytic leukaemia
0.005 0.995 0.000
C91.2 Subacute lymphocytic leukaemia
0.005 0.995 0.000
C95.0 Acute leukaemia of unspecified cell type
0.005 0.995 0.000
C93.9 Monocytic leukaemia, unspecified
0.005 0.995 0.000
C93.7 Other monocytic leukaemia
0.005 0.995 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.005 0.995 0.000
C93.2 Subacute monocytic leukaemia
0.005 0.995 0.000
C93.0 Acute monocytic leukaemia
0.005 0.995 0.000
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters
0.005 0.995 0.000
K82.3 Fistula of gallbladder
0.005 0.995 0.000
I15.0 Renovascular hypertension
0.000 0.995 0.004
T82.1 Mechanical complication of cardiac electronic device
0.005 0.995 0.000
O04.1 Incomplete, complicated by delayed or excessive haemorrhage
0.005 0.995 0.000
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)
0.004 0.995 0.000
C83.0 Small cell (diffuse)
0.004 0.995 0.000
T82.3 Mechanical complication of other vascular grafts
0.004 0.996 0.000
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters
0.004 0.996 0.000
O04 Medical abortion
0.004 0.996 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.004 0.996 0.000
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec
0.004 0.996 0.000
M65.48 Radial styloid tenosynovitis [de Quervain]-Other
0.004 0.996 0.000
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot
0.004 0.996 0.000
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg
0.004 0.996 0.000
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh
0.004 0.996 0.000
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm
0.004 0.996 0.000
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region
0.004 0.996 0.000
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)
0.004 0.996 0.000
C67.2 Lateral wall of bladder
0.004 0.996 0.000
T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft
0.004 0.996 0.000
G82.5 Tetraplegia, unspecified
0.000 0.996 0.004
C90.3 Solitary plasmacytoma
0.004 0.996 0.000
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.996 0.004
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.996 0.004
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.996 0.004
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.996 0.004
I11.0 Hypertensive heart disease with (congestive) heart failure
0.000 0.996 0.004
K65 Peritonitis
0.000 0.996 0.004
C91.5 Adult T-cell leukaemia
0.004 0.996 0.000
O04.4 Incomplete, without complication
0.004 0.996 0.000
C83.5 Lymphoblastic (diffuse)
0.004 0.996 0.000
N00-N08 Glomerular diseases
0.000 0.996 0.004
C94.7 Other specified leukaemias
0.004 0.996 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.004 0.996 0.000
C94.5 Acute myelofibrosis
0.004 0.996 0.000
C94.4 Acute panmyelosis
0.004 0.996 0.000
C94.3 Mast cell leukaemia
0.004 0.996 0.000
C94.2 Acute megakaryoblastic leukaemia
0.004 0.996 0.000
C94.1 Chronic erythraemia
0.004 0.996 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.004 0.996 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.004 0.996 0.000
C96.8 Histiocytic sarcoma
0.004 0.996 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.004 0.996 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.004 0.996 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.004 0.996 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.004 0.996 0.000
C96.3 True histiocytic lymphoma
0.004 0.996 0.000
C96.2 Malignant mast cell tumour
0.004 0.996 0.000
C96.1 Malignant histiocytosis
0.004 0.996 0.000
C96.0 Letterer-Siwe disease
0.004 0.996 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.004 0.996 0.000
C91.0 Acute lymphoblastic leukaemia
0.004 0.996 0.000
G97.8 Other postprocedural disorders of nervous system
0.000 0.996 0.004
N03.1 Focal and segmental glomerular lesions
0.000 0.996 0.004
H61 Other disorders of external ear
0.004 0.996 0.000
H61.0 Perichondritis of external ear
0.004 0.996 0.000
K65.8 Other peritonitis
0.000 0.996 0.004
T82.4 Mechanical complication of vascular dialysis catheter
0.004 0.996 0.000
M24.07 Loose body in joint (Ankle and foot)
0.004 0.996 0.000
C83.6 Undifferentiated (diffuse)
0.004 0.996 0.000
C83.4 Immunoblastic (diffuse)
0.004 0.996 0.000
C83.2 Mixed small and large cell (diffuse)
0.004 0.996 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.004 0.996 0.000
C86.4 Blastic NK-cell lymphoma
0.004 0.996 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.004 0.996 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.004 0.996 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.004 0.996 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.004 0.996 0.000
S02.40 Fracture of malar and maxillary bones (closed)
0.000 0.996 0.004
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.004 0.996 0.000
N03.8 Other
0.000 0.996 0.004
N03.7 Diffuse crescentic glomerulonephritis
0.000 0.996 0.004
N03.6 Dense deposit disease
0.000 0.996 0.004
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.996 0.004
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.996 0.004
N03.2 Diffuse membranous glomerulonephritis
0.000 0.996 0.004
N03.0 Minor glomerular abnormality
0.000 0.996 0.004
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems
0.000 0.996 0.004
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.996 0.004
C81 Hodgkin's disease
0.004 0.996 0.000
C84.5 Other and unspecified T-cell lymphomas
0.004 0.996 0.000
M65.34 Trigger finger-Hand
0.004 0.996 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.004 0.996 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.003 0.996 0.000
G82.4 Spastic tetraplegia
0.000 0.996 0.004
M65.3 Trigger finger
0.004 0.996 0.000
T82.2 Mechanical complication of coronary artery bypass and valve grafts
0.003 0.996 0.000
C83.3 Large cell (diffuse)
0.004 0.996 0.000
M65 Synovitis and tenosynovitis
0.004 0.996 0.000
H74.8 Other specified disorders of middle ear and mastoid
0.000 0.996 0.004
C92 Myeloid leukaemia
0.003 0.996 0.000
O04.8 Complete or unspecified, with other and unspecified complications
0.003 0.997 0.000
O04.7 Complete or unspecified, complicated by embolism
0.003 0.997 0.000
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage
0.003 0.997 0.000
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection
0.003 0.997 0.000
O04.3 Incomplete, with other and unspecified complications
0.003 0.997 0.000
O04.2 Incomplete, complicated by embolism
0.003 0.997 0.000
O04.0 Incomplete, complicated by genital tract and pelvic infection
0.003 0.997 0.000
C83.1 Small cleaved cell (diffuse)
0.003 0.997 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.003 0.997 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.003 0.997 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.003 0.997 0.000
C84.3 Lymphoepithelioid lymphoma
0.003 0.997 0.000
C84.2 T-zone lymphoma
0.003 0.997 0.000
C84.1 Sezary's diease
0.003 0.997 0.000
G82 Paraplegia and tetraplegia
0.000 0.997 0.003
G82.1 Spastic paraplegia
0.000 0.997 0.003
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.003 0.997 0.000
H61.1 Non-infective disorders of pinna
0.003 0.997 0.000
C83.7 Burkitt's tumour
0.003 0.997 0.000
C92.4 Acute promyelocytic leukaemia
0.003 0.997 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.997 0.000
H40.5 Glaucoma secondary to other eye disorders
0.003 0.997 0.000
C81.2 Mixed cellularity
0.003 0.997 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.003 0.997 0.000
N07 Hereditary nephropathy, not elsewhere classified
0.000 0.997 0.003
N06 Isolated proteinuria with specified morphological lesion
0.000 0.997 0.003
N01 Rapidly progressive nephritic syndrome
0.000 0.997 0.003
H61.9 Disorder of external ear, unspecified
0.003 0.997 0.000
L73.8 Other specified follicular disorders
0.003 0.997 0.000
N00 Acute nephritic syndrome
0.000 0.997 0.003
C84.0 Mycosis fungoides
0.003 0.997 0.000
M65.86 Other synovitis and tenosynovitis (Lower leg)
0.000 0.997 0.003
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.997 0.003
Y52 Agents primarily affecting the cardiovascular system
0.003 0.997 0.000
M65.1 Other infective (teno)synovitis
0.003 0.997 0.000
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters
0.003 0.997 0.000
N04 Nephrotic syndrome
0.000 0.997 0.003
C81.7 Other Hodgkin's disease
0.003 0.997 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.003 0.997 0.000
C81.3 Lymphocytic depletion
0.003 0.997 0.000
M65.9 Synovitis and tenosynovitis, unspecified
0.003 0.997 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.003 0.997 0.000
M65.39 Trigger finger-Site unspec
0.003 0.997 0.000
M65.38 Trigger finger-Other
0.003 0.997 0.000
M65.37 Trigger finger-Ankle/foot
0.003 0.997 0.000
M65.36 Trigger finger-Lower leg
0.003 0.997 0.000
M65.35 Trigger finger-Pelvic/thigh
0.003 0.997 0.000
M65.33 Trigger finger-Forearm
0.003 0.997 0.000
M65.32 Trigger finger-Upper arm
0.003 0.997 0.000
M65.31 Trigger finger-Shldr region
0.003 0.997 0.000
M65.30 Trigger finger-Mult sites
0.003 0.997 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.003 0.997 0.000
Z98.1 Arthrodesis status
0.000 0.997 0.003
L73 Other follicular disorders
0.003 0.997 0.000
C81.0 Lymphocytic predominance
0.003 0.997 0.000
M65.2 Calcific tendinitis
0.003 0.997 0.000
M65.0 Abscess of tendon sheath
0.003 0.997 0.000
S52.10 Fracture of upper end of radius (closed)
0.003 0.997 0.000
C92.9 Myeloid leukaemia, unspecified
0.003 0.997 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.003 0.997 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.003 0.997 0.000
C92.5 Acute myelomonocytic leukaemia
0.003 0.997 0.000
C92.3 Myeloid sarcoma
0.003 0.997 0.000
C92.2 Subacute myeloid leukaemia
0.003 0.997 0.000
L73.9 Follicular disorder, unspecified
0.003 0.997 0.000
Y52.1 Calcium-channel blockers
0.003 0.997 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.003 0.997 0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts
0.003 0.997 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.003 0.997 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.003 0.997 0.000
K82.4 Cholesterolosis of gallbladder
0.000 0.997 0.002
M24.0 Loose body in joint
0.003 0.997 0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)
0.003 0.997 0.000
C82.6 Cutaneous follicle centre lymphoma
0.003 0.997 0.000
C82.5 Diffuse follicle centre lymphoma
0.003 0.997 0.000
C82.4 Follicular lymphoma grade IIIb
0.003 0.997 0.000
G82.3 Flaccid tetraplegia
0.000 0.997 0.003
G82.0 Flaccid paraplegia
0.000 0.997 0.003
M65.14 Other infective (teno)synovitis (Hand)
0.003 0.997 0.000
C92.7 Other myeloid leukaemia
0.002 0.997 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.003 0.997 0.000
H61.3 Acquired stenosis of external ear canal
0.003 0.997 0.000
A40.0 Septicaemia due to streptococcus, group A
0.000 0.997 0.003
M13.94 Arthritis, unspecified (Hand)
0.003 0.997 0.000
N43.3 Hydrocele, unspecified
0.000 0.997 0.003
N01.9 Unspecified
0.000 0.997 0.002
N01.8 Other
0.000 0.997 0.002
N01.7 Diffuse crescentic glomerulonephritis
0.000 0.997 0.002
N01.6 Dense deposit disease
0.000 0.997 0.002
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.997 0.002
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.997 0.002
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.997 0.002
N01.2 Diffuse membranous glomerulonephritis
0.000 0.997 0.002
N01.1 Focal and segmental glomerular lesions
0.000 0.997 0.002
N01.0 Minor glomerular abnormality
0.000 0.997 0.002
N06.9 Unspecified
0.000 0.997 0.002
N06.8 Other
0.000 0.997 0.002
N06.7 Diffuse crescentic glomerulonephritis
0.000 0.997 0.002
N06.6 Dense deposit disease
0.000 0.997 0.002
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.997 0.002
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.997 0.002
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.997 0.002
N06.2 Diffuse membranous glomerulonephritis
0.000 0.997 0.002
N06.1 Focal and segmental glomerular lesions
0.000 0.997 0.002
N06.0 Minor glomerular abnormality
0.000 0.997 0.002
N07.9 Unspecified
0.000 0.997 0.002
N07.8 Other
0.000 0.997 0.002
N07.7 Diffuse crescentic glomerulonephritis
0.000 0.997 0.002
N07.6 Dense deposit disease
0.000 0.997 0.002
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.997 0.002
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.997 0.002
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.997 0.002
N07.2 Diffuse membranous glomerulonephritis
0.000 0.997 0.002
N07.1 Focal and segmental glomerular lesions
0.000 0.997 0.002
N07.0 Minor glomerular abnormality
0.000 0.997 0.002
C84.4 Peripheral T-cell lymphoma
0.002 0.997 0.000
E55.9 Vitamin D deficiency, unspecified
0.000 0.997 0.003
N00.8 Other
0.000 0.997 0.002
N00.7 Diffuse crescentic glomerulonephritis
0.000 0.997 0.002
N00.6 Dense deposit disease
0.000 0.997 0.002
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.997 0.002
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.997 0.002
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.997 0.002
N00.2 Diffuse membranous glomerulonephritis
0.000 0.997 0.002
N00.1 Focal and segmental glomerular lesions
0.000 0.997 0.002
N00.0 Minor glomerular abnormality
0.000 0.997 0.002
K82.9 Disease of gallbladder, unspecified
0.002 0.997 0.000
N00.9 Unspecified
0.000 0.997 0.002
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.002 0.997 0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.000 0.997 0.003
S92.40 Fracture of great toe (closed)
0.002 0.997 0.000
R23.8 Other and unspecified skin changes
0.000 0.997 0.002
Y52.7 Peripheral vasodilators
0.002 0.997 0.000
M65.19 Other infective (teno)synovitis (Site unspecified)
0.002 0.998 0.000
M65.18 Other infective (teno)synovitis (Other)
0.002 0.998 0.000
M65.17 Other infective (teno)synovitis (Ankle and foot)
0.002 0.998 0.000
M65.16 Other infective (teno)synovitis (Lower leg)
0.002 0.998 0.000
M65.15 Other infective (teno)synovitis (Pelvic region and thigh)
0.002 0.998 0.000
M65.13 Other infective (teno)synovitis (Forearm)
0.002 0.998 0.000
M65.12 Other infective (teno)synovitis (Upper arm)
0.002 0.998 0.000
M65.11 Other infective (teno)synovitis (Shoulder region)
0.002 0.998 0.000
M65.10 Other infective (teno)synovitis (Multiple sites)
0.002 0.998 0.000
O14.9 Preeclampsia, unspecified
0.002 0.998 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.002 0.998 0.000
L71.9 Rosacea, unspecified
0.002 0.998 0.000
M24.01 Loose body in joint (Shoulder region)
0.002 0.998 0.000
B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters
0.002 0.998 0.000
C67.8 Overlapping lesion of bladder
0.002 0.998 0.000
M65.8 Other synovitis and tenosynovitis
0.001 0.998 0.001
N04.2 Diffuse membranous glomerulonephritis
0.000 0.998 0.002
N04.8 Other
0.000 0.998 0.002
N04.7 Diffuse crescentic glomerulonephritis
0.000 0.998 0.002
N04.6 Dense deposit disease
0.000 0.998 0.002
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.998 0.002
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.998 0.002
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.998 0.002
N04.0 Minor glomerular abnormality
0.000 0.998 0.002
M24.06 Loose body in joint-Lower leg
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.